| Value | ₹62.50 Cr |
|---|
BSE filing, NSE: ALBERTDAVD. Summary written from the filing by ALFA Finder's alert engine.
Albert David Ltd: key numbers
- Share price
- ₹767.95
- Market cap
- ₹438.3 Cr
- Revenue (annual)
- ₹333.6 Cr
- Net profit (annual)
- ₹-1.49 Cr
- P/E (TTM)
- 19.4×Sector 48.7×
- Promoter holding
- 62.24%+0.00% QoQ
- FII holding
- 0.60%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Albert David Ltd
All →Albert David Board Meeting Date
Albert David Limited will hold a board meeting on 12 Nov 2026 to consider unaudited financial results for the quarter and half year ended September 2026. The trading window is already closed from 01 Oct 2026 and reopens 48 hours after results.
Albert David Other Announcement
Albert David Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.
Albert David Annual General Meeting
Albert David Limited submitted the minutes of its 87th Annual General Meeting held on August 6, 2026. The meeting successfully concluded the proposed agenda items.
Albert David Annual General Meeting
Albert David Limited conducted its 87th Annual General Meeting via video conferencing. The meeting covered adoption of financial statements, dividend declaration, and various director appointments.
Albert David Management Change
Dr. Kuntal Ganguly has resigned as Head of R&D at Albert David Limited, effective August 5, 2026.
Albert David Q1 FY27 Results: Net Profit ₹3,200 Cr, Up 303.1% YoY
Albert David Ltd reported revenue from operations of ₹10,134 Cr (+43.6% YoY) and net profit of ₹3,200 Cr (+303.1% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3,200 Cr · +303.1% YoY
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.